Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compugen | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪521.40M | 89.8x | 0.85 | ILA 589.70 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lineage Cell Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪429.63M | -4.9x | -0.35 | ILA 212.50 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Batm | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪352.86M | -220.7x | 1.49 | ILA 82.90 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oramed Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪351.66M | 21.8x | 0.17 | ILA 870 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonus Biogroup | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪181.03M | -6.5x | ILA 15.20 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
DNA Group TR | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪109.12M | 7.3x | 0.02 | ILA 87.90 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enlivex | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪95.11M | -1.2x | -0.04 | ILA 435 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pluri Inc | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪91.77M | -1.1x | -0.04 | ILA 1,643 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kadimastem Ltd | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪64.83M | -35.3x | -0.06 | ILA 1,468 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Matricelf | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪59.77M | ILA 374.40 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
XTL Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪59.05M | -9.1x | -0.32 | ILA 6.70 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLine RX | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪58.79M | -0.8x | -0.02 | ILA 4.90 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evogene | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪40.23M | -0.4x | -0.13 | ILA 600.40 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Purple Biotech | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪37.19M | -0.4x | -0.02 | ILA 7.40 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nextage Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪25.31M | ILA 79.50 | 7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Merchavia | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪11.31M | -1.2x | -0.31 | ILA 68.60 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hadasit Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪6.65M | -0.9x | -0.01 | ILA 52.60 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Univo Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪2.84M | ILA 93,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |